DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones

Active, not recruiting

Conditions: Craniosynostosis

Interventions: Other: Craniosynostosis Network Environmental Survey
Other: 2D/3D Photography
Procedure: Buccal Swab Cell Sampling
Procedure: Blood sampling
Procedure: Skin Biopsy
Procedure: Tissues from a Clinically Indicated Procedure
Procedure: Pre-operative CT Scan Image Files.

First Posted Date: 2017-01-20

Last Posted Date: 2025-01-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 2145

Registration Number: NCT03025763

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
National Birth Defects Prevention Study at University of Iowa, Iowa City, Iowa, United States

and more 17 locations

Vitamin D3 in Patients With Sickle Cell Disease

Completed

Conditions: Sickle Cell Disease

First Posted Date: 2017-01-06

Last Posted Date: 2018-01-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 50

Registration Number: NCT03012555

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Pilot Diet Study for Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: Dietary Intervention
Behavioral: Non-dietary Intervention Arm

First Posted Date: 2016-12-08

Last Posted Date: 2018-10-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 36

Registration Number: NCT02986893

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Hepatitis C Infection in World Trade Center Responders

Completed

Conditions: Hepatitis C Infection

First Posted Date: 2016-12-06

Last Posted Date: 2019-02-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 3906

Registration Number: NCT02982993

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Oral Iron for Erythropoietic Protoporphyrias

Not Applicable

Completed

Conditions: X-linked Protoporphyria
EPP
XLP
Erythropoietic Protoporphyria

Interventions: Drug: Oral Iron

First Posted Date: 2016-12-01

Last Posted Date: 2020-09-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 16

Registration Number: NCT02979249

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸
University of California, San Francisco, California, United States

and more 3 locations

Syncope Decision Aid for Emergency Care

Not Applicable

Completed

Conditions: Syncope

Interventions: Behavioral: SynDA

First Posted Date: 2016-11-22

Last Posted Date: 2020-05-26

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 50

Registration Number: NCT02971163

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Home-based Primary Care for Homebound Seniors

Not Applicable

Terminated

Conditions: Home-bound Adults

Interventions: Other: Usual Care
Other: Home-based Primary Care

First Posted Date: 2016-11-16

Last Posted Date: 2020-10-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 230

Registration Number: NCT02965508

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

Not Applicable

Active, not recruiting

Conditions: Locally Advanced HPV Positive Oropharynx Cancer

Interventions: Radiation: PTV56
Radiation: PTV50.4

First Posted Date: 2016-10-26

Last Posted Date: 2024-07-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 43

Registration Number: NCT02945631

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Phase 2

Terminated

Conditions: High Risk Smoldering Multiple Myeloma

Interventions: Drug: Ibrutinib

First Posted Date: 2016-10-24

Last Posted Date: 2020-12-16

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 9

Registration Number: NCT02943473

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: Tamoxifen
Drug: Fulvestrant

First Posted Date: 2016-10-18

Last Posted Date: 2021-05-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 2

Registration Number: NCT02936206

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States
🇺🇸
Mount Sinai St. Luke's, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy